Implementation of an Interprofessional Team to Prevent Inpatient Hypoglycemic Events. November 12, 2016

Size: px
Start display at page:

Download "Implementation of an Interprofessional Team to Prevent Inpatient Hypoglycemic Events. November 12, 2016"

Transcription

1 Implementation of an Interprofessional Team to Prevent Inpatient Hypoglycemic Events November 12, 2016

2 St Joseph s Health Fast Facts Founded 1869 by Sisters of St. Francis Patient Volumes (2014) Inpatient discharges: 27,635 Primary Care Visits: 66,554 Emergency Department Visits: 66,835 Psychiatric Emergency Program: 13,464 Outpatient Surgeries: 9,791 Home Healthcare Admissions: 6,332 Employees FTEs: 3,636 Volunteers: 500 Medical Staff Physicians and Dentists: 870

3 Diabetic Glycemic Control High proportion of diabetes in Onondaga County. Onondaga: 13.9% National: 10.4% & New York: 9.4% Insulin administered 23% Hospital Days at St Joseph s

4 Morbidity and Mortality associated with Severe Hypoglycemia Current Medical Research & Opinion 29: , Increased in inpatient mortality risk: <70 mg/dl adjusted odds ratio (OR) 1.66 <50 mg/dl adjusted odds ratio (OR) Increase LOS: 8.2 vs. 5.2 days. Diabet. Med. 12:e445-8, Increase in inpatient mortality risk: mg/dl adjusted odds ratio (OR) 1.62 <40 mg/dl adjusted odds ratio (OR) Increase LOS cw >70mg/dL group: mg/dl 1.51 fold <40 mg/dl 2.33 fold

5 Hypoglycemia 5.19% vs NYSPFP 6.99% (Inpatients with at least one glucose <50mg/dL/100 prescribed insulin) vs Current Medical Research & Opinion 29: , %

6 Hypoglycemia Initiatives 1. Interprofessional Hypoglycemia Response Team. 2. Revised Sub Q insulin protocol. 3. House-wide education: insulin regimens. 4. Leverage new EHR to create actionable and analytical reports

7 Hypoglycemia Response Team Interprofessional Team: Endocrinology Pharmacy Dietary Nursing Patients with severe hypoglycemia <50mg/dL identified. Daily EPIC EHR report Plan formulated and attending provider contacted.

8 Daily Severe Hypoglycemia Report No Patients!

9 Lantus Insulin Protocol Proactively identify patients at risk for severe hypoglycemia. Patients with a fasting glucose 100 mg/dl identified. Daily EPIC EHR report. Pharmacy provides Lantus to floors. Glucose mg/dl: pharmacy decreases Lantus by 20%. Glucose <70 mg/dl: hypoglycemia protocol started and provider contacted.

10

11 Rate per 1000 Pt-Ins days Severe Hypoglycemic Episodes (<50mg/dL) Initiation Hypoglycemia Response Team and Pharmacy Lantus Protocol

12 Percent Patients treated with Insulin with Hypoglycemic Episode Severe Hypoglycemic Episodes (<50mg/dL) Initiation Hypoglycemia Response Team and Pharmacy Lantus Protocol

13 Patients treated with Insulin with Hypoglycemic Episode Severe Hypoglycemic Episodes (<50mg/dL) Initiation Hypoglycemia Response Team and Pharmacy Lantus Protocol

14 Percent Pt-Insulin Days Avg Glc > 200 mg/dl Inpatient Hyperglycemia Initiation Hypoglycemia Response Team and Pharmacy Lantus Protocol

15 Rate per 1000 Pt-Ins days 4 Repeat Severe Hypoglycemic Episodes (<50mg/dL) Initiation Hypoglycemia Response Team and Pharmacy Lantus Protocol

16 Rate per 1000 Pt-Ins days Severe Hypoglycemic Episodes (<50mg/dL) and Hyperkalemia Initiation Hypoglycemia Response Team and Pharmacy Lantus Protocol Hyperkalemia OS Final K+ guidelines 50g bolus D10

17 Percent Insulin Administrations 25% Severe Hypoglycemia and Insulin Adminstration for Hyperkalemia Treatment 20% Hyperkalemia OS Final K+ guidelines 50g bolus D10 15% 10% 5% 0%

18 Hyperkalemia Treatment Order Set Medications

19 Timing POC Glc and Insulin Administration

20 Percent POC Glc to Insulin Admin <=30min POC Glc to Insulin Admin Initiative to decrease variability in glucose testing to insulin administration time: unit and clinician metrics.

21 Percent Change Last Mos:2015 POC Glc to Insulin Admin <=30min POC Glc to Insulin Admin

22 Percent Change Last Mos:2015 POC Glc to Insulin Admin <=30min POC Glc to Insulin Admin

23 Summary Reduction of hypoglycemic episodes <50mg/dL by 44% Reduction of repeat episodes by 78% Treatment of Hyperkalemia: 16% episodes 5.6% after Order Set Optimization Timing POC Glc-Insulin Admin <30min 60% to 75% administrations No initial but gradual increase in hyperglycemia

24 Lessons Learned Interprofessional team is a powerful resource. A team of key stake-holders critical Amplified knowledge Amplifies manpower Identify and make system changes All levels of patient care

25 Daily patient reviews identify areas for focused improvement: Timing of insulin dosing Stacking A la carte meals Lessons Learned Frequency POC glucose IV insulin Creative community insulin regimens Hypoglycemia associated with hyperkalemia treatment Order set incorporating insulin, glucose, monitoring

26 Lessons Learned Ripple effect of principles from Core Group. Key insulin regimen principles knowledge Permeate throughout community to improve diabetes care

27 Acknowledgements Dr. Marya Gendzielewski, Endocrinology Dr. Grant Kelley, Endocrinology Bernie Delello, Pharmacy Director Alecia Hehfoster, Pharmacy Sarah Linnertz, Pharmacy Kristen Bradshaw, Pharmacy Susan Branning, Clinical Dietician Sue Rioux, Diabetes Educator Christopher Jordan, Director of Quality

Implementation of an Interprofessional Team to Prevent Inpatient Hypoglycemic Events. September 13, 2016

Implementation of an Interprofessional Team to Prevent Inpatient Hypoglycemic Events. September 13, 2016 Implementation of an Interprofessional Team to Prevent Inpatient Hypoglycemic Events September 13, 2016 St Joseph s Health Fast Facts Founded 1869 by Sisters of St. Francis Patient Volumes (2014) Inpatient

More information

Hypoglycemia Task Force: A Quality Improvement Initiative to Reduce Inpatient Hypoglycemia

Hypoglycemia Task Force: A Quality Improvement Initiative to Reduce Inpatient Hypoglycemia Hypoglycemia Task Force: A Quality Improvement Initiative to Reduce Inpatient Hypoglycemia Shiv Patil, MD, MPH, BC-ADM Clinical Assistant Professor of Family Medicine Brody School of Medicine at East Carolina

More information

Insulin Regimens: Hitting Glycemia Targets

Insulin Regimens: Hitting Glycemia Targets Insulin Regimens: Hitting Glycemia Targets Grant Kelley MD March 1 st, 2018 Faculty Disclosure: Financial relationships with commercial interests None Overview Mortality and Morbidity Insulin and Insulin

More information

Lessons Learned: Interdisciplinary collaboration to reduce hypoglycemic events

Lessons Learned: Interdisciplinary collaboration to reduce hypoglycemic events Lessons Learned: Interdisciplinary collaboration to reduce hypoglycemic events Ryan ull, Pharm.., BCPS ssistant Professor of Pharmacy Practice Creighton niversity School of Pharmacy legent Health Lakeside

More information

APPENDIX American Diabetes Association. Published online at

APPENDIX American Diabetes Association. Published online at APPENDIX 1 INPATIENT MANAGEMENT OF TYPE 2 DIABETES No algorithm applies to all patients with diabetes. These guidelines apply to patients with type 2 diabetes who are not on glucocorticoids, have no

More information

Montgomery General Hospital- Medstar Healthcare Improving Glycemic Control to Enhance Patient Outcomes

Montgomery General Hospital- Medstar Healthcare Improving Glycemic Control to Enhance Patient Outcomes Organization: Solution Title: Montgomery General Hospital- Medstar Healthcare Improving Glycemic Control to Enhance Patient Outcomes Program/Project Description:What was the problem to be solved? How was

More information

Glycemic Control Hitting the Sweet Spot During Inpatient Care

Glycemic Control Hitting the Sweet Spot During Inpatient Care Glycemic Control Hitting the Sweet Spot During Inpatient Care Tim R. Brown, PharmD, BCACP, FASHP Director of Clinical Pharmacotherapy, Family Medicine Cleveland Clinic Akron General Professor, Northeast

More information

A Children s Bedtime Story

A Children s Bedtime Story A Children s Bedtime Story Setting: University Medical Center, Big Town, USA Scenario: 0500, last admission of the night, 10 previous admissions, all tucked in for the night Patient: 75 year old male with

More information

Hypoglycemia Reduction STARTER PACK WEBINAR #1

Hypoglycemia Reduction STARTER PACK WEBINAR #1 Hypoglycemia Reduction STARTER PACK WEBINAR #1 Why is it important to reduce hypoglycemia? Why Hypoglycemia Reduction? Key Statistics Overall 29% reduction in ADEs since 2010 Hypoglycemia still occurs

More information

Guide to Finding Your Hospital s Adverse Drug Event (ADE) Rates. Step-by-Step Data Collection Guide for Collecting the Six ADE Measures

Guide to Finding Your Hospital s Adverse Drug Event (ADE) Rates. Step-by-Step Data Collection Guide for Collecting the Six ADE Measures Guide to Finding Your Hospital s Adverse Drug Event (ADE) Rates Step-by-Step Data Collection Guide for Collecting the Six ADE Measures 1 Anticoagulation Outcome Measure International Normalized Ratio (INR)

More information

New Approach to Reducing Adverse Drug Events Anticoagulants Insulin Opioids

New Approach to Reducing Adverse Drug Events Anticoagulants Insulin Opioids New Approach to Reducing Adverse Drug Events Anticoagulants Insulin Opioids October 9, 2013 A partnership of the Healthcare Association of New York State and the Greater New York Hospital Association NYSPFP

More information

NOT-SO-SWEET! THE STRAIGHT SCOOP ON DIABETES IN THE HOSPITAL SETTING

NOT-SO-SWEET! THE STRAIGHT SCOOP ON DIABETES IN THE HOSPITAL SETTING Sharp HealthCare s 2016 Diabetes Conference November 11, 2016 NOT-SO-SWEET! THE STRAIGHT SCOOP ON DIABETES IN THE HOSPITAL SETTING Tamara Swigert, MSN, RN, CDE Speaker Disclosure Tammy Swigert has no conflicts

More information

AACE Module on Patient Safety in Inpatient Diabetes Care

AACE Module on Patient Safety in Inpatient Diabetes Care AACE Module on Patient Safety in Inpatient Diabetes Care Richard Hellman, MD, FACP, FACE Past President, American Association of Clinical Endocrinologists Clinical Professor of Medicine, University of

More information

Session 15 Improved Outcomes and a Proven ROI Model for Quality Improvement: Transforming Diabetes Care

Session 15 Improved Outcomes and a Proven ROI Model for Quality Improvement: Transforming Diabetes Care Session 15 Improved Outcomes and a Proven ROI Model for Quality Improvement: Transforming Diabetes Care Charles G Macias MD, MPH Chief Clinical Systems Integration Officer Director of Evidence-Based Outcomes

More information

Faculty. Disclosures. Prescribing. A Multidisciplinary Approach to Preventing Medication Errors Associated with Insulin Therapy. Learning Objectives

Faculty. Disclosures. Prescribing. A Multidisciplinary Approach to Preventing Medication Errors Associated with Insulin Therapy. Learning Objectives A Multidisciplinary Approach to Preventing Medication Errors Associated with Insulin Therapy Faculty Matthew Grissinger, RPh, FISMP, FASCP Director, Error Reporting Programs Institute for Safe Medication

More information

Glycemic Control IU Health Diabetes Centers

Glycemic Control IU Health Diabetes Centers Glycemic Control IU Health Diabetes Centers Central Nursing Orientation 3/10/2014 1 Objectives Identify laboratory results that diagnosis diabetes and reflect glycemic control Describe glycemic control

More information

Using the Bolus Wizard Calculator

Using the Bolus Wizard Calculator 9501179-011 Using the Bolus Wizard Calculator Objective Describe the features and benefits of the Bolus Wizard Calculator Key Points The Bolus Wizard: Estimates high blood glucose corrections using the

More information

8/14/2016. Inpatient Strategies to Drive Hospital Systems Towards the Triple Aim Goals in Diabetes Care. Objectives. Disclosure to Participants

8/14/2016. Inpatient Strategies to Drive Hospital Systems Towards the Triple Aim Goals in Diabetes Care. Objectives. Disclosure to Participants Inpatient Strategies to Drive Hospital Systems Towards the Triple Aim Goals in Diabetes Care Joyce Najarian MSN, RN, CDE Program Manager, Inpatient Diabetes Department of Medicine Lehigh Valley Health

More information

Self-assessment checklist

Self-assessment checklist Self-assessment checklist 1 1 All hospitals should have a fully staffed diabetes inpatient team, made up of the following 1 : consultant. Sufficient diabetes inpatient specialist nurses to run a daily

More information

The Hospitalized Child with Diabetes/Hyperglycemia: Don t Sugar Coat It

The Hospitalized Child with Diabetes/Hyperglycemia: Don t Sugar Coat It The Hospitalized Child with Diabetes/Hyperglycemia: Don t Sugar Coat It Cassie Brady, MD Assistant Professor of Pediatrics Division of Endocrinology and Diabetes Monroe Carell Junior Children s Hospital

More information

Hypoglycemia and Quality Measurement

Hypoglycemia and Quality Measurement Hypoglycemia and Quality Measurement Sam Stolpe Senior Director The Triple Aim Affordable Care Better Care Healthy People/ Communities 1 Comprehensive Overview of CMS Quality Programs Hospital Quality

More information

Αναγκαιότητα και τρόπος ρύθμισης του διαβήτη στους νοσηλευόμενους ασθενείς

Αναγκαιότητα και τρόπος ρύθμισης του διαβήτη στους νοσηλευόμενους ασθενείς Αναγκαιότητα και τρόπος ρύθμισης του διαβήτη στους νοσηλευόμενους ασθενείς Αναστασία Θανοπούλου Επίκουρη Καθηγήτρια Β Παθολογικής Κλινικής Πανεπιστημίου Αθηνών Διαβητολογικό Κέντρο, Ιπποκράτειο Νοσοκομείο

More information

Improving Inpatient Diabetes Care: Focus on Safe Use of Anti-diabetic Therapies

Improving Inpatient Diabetes Care: Focus on Safe Use of Anti-diabetic Therapies Improving Inpatient Diabetes Care: Focus on Safe Use of Anti-diabetic Therapies Leigh Briscoe-Dwyer, PharmD, BCPS, FASHP Chief Pharmacy and Medication Safety Officer North Shore Long Island Jewish Health

More information

Mixed Insulins Pick Me

Mixed Insulins Pick Me Mixed Insulins Pick Me Alvin Goo, PharmD Clinical Associate Professor University of Washington School of Pharmacy and Department of Family Medicine Objectives Critically evaluate the evidence comparing

More information

Accurate Timing of Insulin Administration.

Accurate Timing of Insulin Administration. Lehigh Valley Health Network LVHN Scholarly Works Patient Care Services / Nursing Accurate Timing of Insulin Administration. Elizabeth Ajamu BSN, RN Lehigh Valley Health Network, elizabeth_o.ajamu@lvhn.org

More information

DISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics.

DISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics. DISCLAIMER: Video will be taken at this clinic and potentially used in Project ECHO promotional materials. By attending this clinic, you consent to have your photo taken and allow Project ECHO to use this

More information

Managing Diabetes and Hyperglycemia Safely in the Complex Hospital Setting

Managing Diabetes and Hyperglycemia Safely in the Complex Hospital Setting Managing Diabetes and Hyperglycemia Safely in the Complex Hospital Setting Greg Maynard MD, MSc Clinical Professor of Medicine and CQO, UC Davis Medical Center Sacramento, CA Greg Maynard Disclosure SHM

More information

Meeting the Challenge of Inpatient Glycemic Management in the Non-Critical Care Setting

Meeting the Challenge of Inpatient Glycemic Management in the Non-Critical Care Setting Meeting the Challenge of Inpatient Glycemic Management in the Non-Critical Care Setting Jane Jeffrie Seley, DNP, MPH, GNP, BC-ADM, CDE, CDTC, FAAN, FAADE Diabetes Nurse Practitioner, Inpatient Diabetes

More information

HIMSS Davies Enterprise Award Submission

HIMSS Davies Enterprise Award Submission HIMSS Davies Enterprise Award Submission Applicant Organization: St. Clair Hospital Organization s Address: 1000 Bower Hill Road, Pittsburgh, PA, 15243 Submitter s Name: Richard J. Schaeffer Submitter

More information

9/23/09. What are the key components of preoperative, intraoperative, & postoperative care of diabetes management? Rebecca L. Sturges, M.D.

9/23/09. What are the key components of preoperative, intraoperative, & postoperative care of diabetes management? Rebecca L. Sturges, M.D. RMHS Perioperative Summit: Perioperative Diabetes Management Rebecca L. Sturges, M.D. Oct 6, 2009 Mrs. B was referred by her orthopedic surgeon to your preoperative clinic to discuss medical management

More information

GLYCEMIC CONTROL SURVEY

GLYCEMIC CONTROL SURVEY GLYCEMIC CONTROL SURVEY Objective: To gain an understanding of the current state of glycemic control (ie, intensive insulin therapy and frequent blood glucose testing) protocol use in hospital inpatients.

More information

Hypoglycemia Prevention and Management - Measurement that Matters and the Power of Collaboration

Hypoglycemia Prevention and Management - Measurement that Matters and the Power of Collaboration Hypoglycemia Prevention and Management - Measurement that Matters and the Power of Collaboration Greg Maynard M.D., Clinical Professor of Medicine Director, UCSD Center for Innovation and Improvement Science

More information

Peripartum and Postpartum Management of Diabetes

Peripartum and Postpartum Management of Diabetes Peripartum and Postpartum Management of Diabetes General Principles Glucose goal ~ 100 mg/dl (70-110 mg/dl) Labor is EXERCISE with increased metabolic demands. Insulin requirements decrease however the

More information

DIABETES MANAGEMENT DISCHARGE COMMUNICATION (DM-DC) AUDIT TOOL

DIABETES MANAGEMENT DISCHARGE COMMUNICATION (DM-DC) AUDIT TOOL DIABETES MANAGEMENT DISCHARGE COMMUNICATION (DM-DC) AUDIT TOOL Facility: Date: Data Collector s name: Email/Phone: Purpose: To evaluate your facility practices regarding communication of requisite diabetes

More information

Transition of Care in Hospitalized Patients with Hyperglycemia and Diabetes

Transition of Care in Hospitalized Patients with Hyperglycemia and Diabetes Transition of Care in Hospitalized Patients with Hyperglycemia and Diabetes Critically ill patients in the ICU Hospital Non-ICU Settings Home Guillermo E Umpierrez, MD, FACP, FACE Professor of Medicine

More information

Deepika Reddy MD Department of Endocrinology

Deepika Reddy MD Department of Endocrinology Deepika Reddy MD Department of Endocrinology Management of hyperglycemic crisis Review need for inpatient glycemic control Brief overview of relevant trials Case based review of diabetes management strategies/review

More information

Practical Predictive Analytics. John Cuddeback, MD, PhD AMA IPPS November 11, 2016

Practical Predictive Analytics. John Cuddeback, MD, PhD AMA IPPS November 11, 2016 Practical Predictive Analytics John Cuddeback, MD, PhD AMA IPPS November 11, 2016 AMGA s Work in Analytics Advocacy: Align payment incentives around population health Programs: Help members redesign delivery

More information

Diabetes Survival Skills

Diabetes Survival Skills Promoting Patient Survival with Diabetes Survival Skills Need to know skills for persons with diabetes Susan Zontine, NP-C WMC Diabetes Stewardship team Objectives: Review & understand basic diabetes survival

More information

Inpatient Management of Diabetes Mellitus. Jessica Garza, Pharm.D. PGY-1 Pharmacotherapy Resident TTUHSC School of Pharmacy

Inpatient Management of Diabetes Mellitus. Jessica Garza, Pharm.D. PGY-1 Pharmacotherapy Resident TTUHSC School of Pharmacy Inpatient Management of Diabetes Mellitus Jessica Garza, Pharm.D. PGY-1 Pharmacotherapy Resident TTUHSC School of Pharmacy 2 Disclosure Jessica Garza does not have any actual or potential conflicts of

More information

April Dear (Editor):

April Dear (Editor): April 2014 Dear (Editor): Registered Dietitians (RD) play an integral role in patient care in the medical intensive care unit. RD s have increased knowledge in blood glucose control and reducing adverse

More information

Actionable Patient Safety Solution (APSS) #3C: IMPROVE PREVENTION OF SEVERE HYPOGLYCEMIA

Actionable Patient Safety Solution (APSS) #3C: IMPROVE PREVENTION OF SEVERE HYPOGLYCEMIA Actionable Patient Safety Solution (APSS) #3C: IMPROVE PREVENTION OF SEVERE HYPOGLYCEMIA Endorsed by: The trademarks listed above are used with permission of the respective owners. Executive Summary Checklist

More information

Mentors on Discharge

Mentors on Discharge Mentors on Discharge Repeated psychiatric hospitalizations are costly, impede recovery and are demoralizing to individuals, families, and clinicians. Between 40 to 50 percent of patients with a history

More information

123 Are You Providing Evidence-Based Diabetes Care? - Martin

123 Are You Providing Evidence-Based Diabetes Care? - Martin Donna Martin, DNP, RN, CDE, CMSRN Lewis University Learner will be able to: Identify current inpatient standards of care for patients with diabetes Describe causes of hyperglycemia / hypoglycemia in the

More information

Sponsor / Company: Sanofi Drug substance(s): Insulin Glargine. Study Identifiers: NCT

Sponsor / Company: Sanofi Drug substance(s): Insulin Glargine. Study Identifiers: NCT These results are supplied for informational purposes only. Prescribing decisions should be made based on the approved package insert in the country of prescription. Sponsor / Company: Sanofi Drug substance(s):

More information

Learning Objectives. Perioperative SWEET Success

Learning Objectives. Perioperative SWEET Success Perioperative SWEET Success PERIOPERATIVE SWEET SUCCESS PRESENTED BY: KENDRA MARTIN, RN, BSN, CDE JENNIFER SIMPSON, RN, BC-ADM, MSN, CNS Disclosure to Participants Notice of Requirements For Successful

More information

Improved IPGM: Demonstrating the Value to both Patients and Hospitals

Improved IPGM: Demonstrating the Value to both Patients and Hospitals Improved IPGM: Demonstrating the Value to both Patients and Hospitals Osama Hamdy, MD, PhD, FACE Medical Director, Inpatient Diabetes Program Joslin Diabetes Center Harvard Medical School, Boston, MA Cost

More information

Inpatient Diabetes Management: The Slippery Slope of Sliding Scale Insulin

Inpatient Diabetes Management: The Slippery Slope of Sliding Scale Insulin Inpatient Diabetes Management: The Slippery Slope of Sliding Scale Insulin David Newman, MD University of North Dakota School of Medicine Sanford Health Big Sky Conference 2017 Dr. David Newman, Personal/Professional

More information

Position Statement of ADA / EASD 2012

Position Statement of ADA / EASD 2012 Management of Hyperglycemia in Type2 Diabetes: A Patient- Centered Approach Position Statement of ADA / EASD 2012 Cause of : Type 2 diabetes Cardiovascular disorders Blindness End-stage renal failure Amputations

More information

Comparative Effectiveness, Safety, and Indications of Insulin Analogues in Premixed Formulations for Adults With Type 2 Diabetes Executive Summary

Comparative Effectiveness, Safety, and Indications of Insulin Analogues in Premixed Formulations for Adults With Type 2 Diabetes Executive Summary Number 14 Effective Health Care Comparative Effectiveness, Safety, and Indications of Insulin Analogues in Premixed Formulations for Adults With Type 2 Diabetes Executive Summary Background and Key Questions

More information

Diabetes Survival Skills

Diabetes Survival Skills Promoting Patient Survival with Diabetes Survival Skills Need to know skills for persons with diabetes Susan Zontine, NP-C WMC Diabetes Stewardship team May 18, 2015 Diabetes Chronic illness with serious

More information

CareLink. software REPORT REFERENCE GUIDE. Management Software for Diabetes

CareLink. software REPORT REFERENCE GUIDE. Management Software for Diabetes CareLink Management Software for Diabetes software REPORT REFERENCE GUIDE How to use this guide Each type of CareLink report and its components are described in the following sections. Report data used

More information

Diabetes Education Update November, 2014

Diabetes Education Update November, 2014 Diabetes Education Update November, 2014 AMY: 4 days per week Lead outpatient pediatric and teen educator Can see some adults PRN, especially young adults Schedule: DCAM clinic MON, TUES, WED AND FRI.

More information

ALL orders are active unless: 1. Order is manually lined through to inactivate 2. Orders with check boxes ( ) are unchecked

ALL orders are active unless: 1. Order is manually lined through to inactivate 2. Orders with check boxes ( ) are unchecked Available at: BMC-B BMC-D BMC-N BMC-S Condition/Status ***(NOTE)***For purpose of this DKA Regimen, DKA is considered clear only when the CO2 is GREATER than 18 meq/l and the anion gap is LESS than 12

More information

Intensive Insulin in the Intensive Care Unit

Intensive Insulin in the Intensive Care Unit TABLE OF CONTENTS Introduction to Intensive Insulin in Adult Critical Care Patients - UIMCC Guideline for Insulin Infusion in Adult ICU Patients - P&T Committee Formulary Action Intensive Insulin in the

More information

Basal Bolus Insulin Therapy Frequently Asked Questions

Basal Bolus Insulin Therapy Frequently Asked Questions 1. What is Basal Bolus Insulin Therapy (BBIT)? 2. What evidence supports the use of subcutaneous Basal Bolus Insulin Therapy? 3. Does Basal Bolus Insulin Therapy apply to all patients? 4. What s wrong

More information

Special Situations 1

Special Situations 1 Special Situations 1 Outline Continuous Nutrition Tube feeds TPN Steroids Pumps Perioperative BG Control 2 Patient receiving continuous TF or TPN Continuous nutrition coverage options: Analog q4hr Regular

More information

Cambia Palliative Care Metrics: Where are we and where are we going?

Cambia Palliative Care Metrics: Where are we and where are we going? Cambia Palliative Care Metrics: Where are we and where are we going? J. Randall Curtis, MD, MPH Director, Cambia Palliative Care Center of Excellence www.uwpalliativecarecenter.com Overview of System-Wide

More information

Diabetes Case Study: Co-morbidity of Nonadherence

Diabetes Case Study: Co-morbidity of Nonadherence Diabetes Case Study: Co-morbidity of Nonadherence Maureen Dever, MSN, CRNP, PPCNP.BC, CDE PENS 5/18 Comorbidity of Diabetes Case Study Objective: the learner will discuss an underreported comorbidity of

More information

The clinical trial information provided in this public disclosure synopsis is supplied for informational purposes only.

The clinical trial information provided in this public disclosure synopsis is supplied for informational purposes only. The clinical trial information provided in this public disclosure synopsis is supplied for informational purposes only. Please note that the results reported in any single trial may not reflect the overall

More information

NOTE: The first appearance of terms in bold in the body of this document (except titles) are defined terms please refer to the Definitions section.

NOTE: The first appearance of terms in bold in the body of this document (except titles) are defined terms please refer to the Definitions section. TITLE TREATMENT OF HYPERGLYCEMIA - ADULT SCOPE Provincial: Acute Care APPROVAL AUTHORITY Clinical Operations Executive Committee SPONSOR Diabetes, Obesity & Nutrition Strategic Clinical Network PARENT

More information

Diabetes Case Study: Co-morbidity of Nonadherence Maureen Dever, MSN, CRNP, PPCNP.BC, CDE PENS 5/18

Diabetes Case Study: Co-morbidity of Nonadherence Maureen Dever, MSN, CRNP, PPCNP.BC, CDE PENS 5/18 Diabetes Case Study: Co-morbidity of Nonadherence Maureen Dever, MSN, CRNP, PPCNP.BC, CDE PENS 5/18 Comorbidity of Diabetes Case Study Objective: the learner will discuss an underreported comorbidity of

More information

Index. Note: Page numbers of article titles are in boldface type.

Index. Note: Page numbers of article titles are in boldface type. Index Note: Page numbers of article titles are in boldface type. A ACCORD (Action to Control Cardiovascular Disease and Diabestes), blood pressure goal, 74 ACEIs (Angiotensin-converting enzyme inhibitors),

More information

State of California Health and Human Services Agency Department of Health Care Services

State of California Health and Human Services Agency Department of Health Care Services State of California Health and Human Services Agency Department of Health Care Services JENNIFER KENT Director EDMOND G. BROWN JR Governor DATE: N.L.: 03-0317 Index: Benefits TO: ALL COUNTY CALIFORNIA

More information

Disclosures. Glycemic Control in the Intensive Care Unit. Objectives. Hyperglycemia. Hyperglycemia. History. No disclosures

Disclosures. Glycemic Control in the Intensive Care Unit. Objectives. Hyperglycemia. Hyperglycemia. History. No disclosures Disclosures Glycemic Control in the Intensive Care Unit No disclosures Jorie Frasiolas, Pharm.D., BCPS Clinical Pharmacy Manager, CTICU NewYork-Presbyterian Hospital Columbia University Medical Center

More information

Pharmacist Opportunities within Telemedicine

Pharmacist Opportunities within Telemedicine Pharmacist Opportunities within Telemedicine Bryan Robinette, PharmD, BCPS-AQ Cardiology, Sonia Everhart, PharmD, BCPS, BCCCP Desiree Kosmisky, PharmD, BCCCP March 13 th, 2017 Disclosures Sonia Everhart,

More information

GLYCEMIC CONTROL IN NEUROCRITICAL CARE PATIENTS

GLYCEMIC CONTROL IN NEUROCRITICAL CARE PATIENTS GLYCEMIC CONTROL IN NEUROCRITICAL CARE PATIENTS David Zygun MD MSc FRCPC Professor and Director Division of Critical Care Medicine University of Alberta Zone Clinical Department Head Critical Care Medicine,

More information

Section of Endocrinology, Rush University Medical Center, Chicago, Illinois.

Section of Endocrinology, Rush University Medical Center, Chicago, Illinois. ORIGINAL RESEARCH Treatment of Inpatient Hyperglycemia Beginning in the Emergency Department: A Randomized Trial Using Insulins Aspart and Detemir Compared With Usual Care Jennifer B. Bernard, MD Christina

More information

Neonatal Diabetes. Objectives. Conflicts of Interest Disclosure. No conflicts of interest related to the content of this presentation

Neonatal Diabetes. Objectives. Conflicts of Interest Disclosure. No conflicts of interest related to the content of this presentation Neonatal Diabetes Shannon Abernethy BSN, RN, CPN Pediatric Nurse Navigator Bon Secours Virginia Medical Group Pediatric Endocrinology and Diabetes Associates 1 Objectives Identify and define neonatal diabetes

More information

Advocating for Occupational Therapy s Role in Diabetes Management. Milwaukee VA Medical Center Abbey Lacey, OTS

Advocating for Occupational Therapy s Role in Diabetes Management. Milwaukee VA Medical Center Abbey Lacey, OTS Advocating for Occupational Therapy s Role in Diabetes Management Milwaukee VA Medical Center Abbey Lacey, OTS Objectives! Overview! Advocacy project! Case study Overview! Type II diabetes results when

More information

CTAF Overview. Agenda. Evidence Review. Insulin Degludec (Tresiba, Novo Nordisk) for the Treatment of Diabetes

CTAF Overview. Agenda. Evidence Review. Insulin Degludec (Tresiba, Novo Nordisk) for the Treatment of Diabetes CTAF Overview Insulin Degludec (Tresiba, Novo Nordisk) for the Treatment of Diabetes February 12, 2016 Core program of the Institute for Clinical and Economic Review (ICER) Goal: Help patients, clinicians,

More information

Module 5. Understanding Insulin Therapy

Module 5. Understanding Insulin Therapy Module 5. Understanding Insulin Therapy EDUCATIONAL OBJECTIVES Upon completion of this activity, participants will be better able to: 1. Define the basic physiologic concept of basal-bolus insulin; 2.

More information

HAP PA-HEN Achieving More Together

HAP PA-HEN Achieving More Together HAP PA-HEN Achieving More Together Managing Hyperglycemia in the Hospital: Strategies for Safe and Effective Care Pennsylvania Patient Safety Authority Managing Hyperglycemia in the Hospital: Strategies

More information

Clinical Data and Affect Change

Clinical Data and Affect Change Visualize Granularities of Clinical Data and Affect Change Thomas Carlough, PharmD Pharmacy Services Data Coordinator Oh the things we ll talk about 1. Suffer the Past Processes Walk through the technology

More information

ADA 2018 JUN 25, 2018 ORLANDO, FLORIDA

ADA 2018 JUN 25, 2018 ORLANDO, FLORIDA ADA 2018 JUN 25, 2018 ORLANDO, FLORIDA FORWARD LOOKING STATEMENTS This presentation contains forward-looking statements. They are based on current assumptions and expectations that involve uncertainties

More information

Diabetes Technology Continuous Subcutaneous Insulin Infusion Therapy And Continuous Glucose Monitoring In Adults: An Endocrine Society Clinical

Diabetes Technology Continuous Subcutaneous Insulin Infusion Therapy And Continuous Glucose Monitoring In Adults: An Endocrine Society Clinical Diabetes Technology Continuous Subcutaneous Insulin Infusion Therapy And Continuous Glucose Monitoring In Adults: An Endocrine Society Clinical Practice Guideline Task Force Members Anne Peters, MD (Chair)

More information

HYPERGLYCEMIA MANAGEMENT PROTOCOL A BASAL/BOLUS REGIMEN. Kacy Aderhold, MSN, APRN-CNS, CMSRN

HYPERGLYCEMIA MANAGEMENT PROTOCOL A BASAL/BOLUS REGIMEN. Kacy Aderhold, MSN, APRN-CNS, CMSRN HYPERGLYCEMIA MANAGEMENT PROTOCOL A BASAL/BOLUS REGIMEN Kacy Aderhold, MSN, APRN-CNS, CMSRN Hyperglycemia Management Protocol Mimics the body s normal pancreas function, releasing a slow steady amount

More information

The Diamond Study: Continuous Glucose Monitoring In Patients on Mulitple Daily Insulin Injections

The Diamond Study: Continuous Glucose Monitoring In Patients on Mulitple Daily Insulin Injections 8/5/217 The Diamond Study: Continuous Glucose Monitoring In Patients on Mulitple Daily Insulin Injections Richard M. Bergenstal, MD Executive Director International Diabetes Center at Park Nicollet Minneapolis,

More information

Initiation and Titration of Insulin in Diabetes Mellitus Type 2

Initiation and Titration of Insulin in Diabetes Mellitus Type 2 Initiation and Titration of Insulin in Diabetes Mellitus Type 2 Greg Doelle MD, MS April 6, 2016 Disclosure I have no actual or potential conflicts of interest in relation to the content of this lecture.

More information

Topics in Inpatient Glycemic Control

Topics in Inpatient Glycemic Control Topics in Inpatient Glycemic Control Jane Jeffrie Seley DNP MPH MSN GNP BC-ADM CDE CDTC FAADE FAAN Diabetes Nurse Practitioner Program Manager, Inpatient Glycemic Control Program NewYork-Presbyterian/

More information

DIABETES Self Directed Test (12 Hours) Name: Ward/Practice Area: Mailing Address:

DIABETES Self Directed Test (12 Hours) Name: Ward/Practice Area: Mailing Address: 1 DIABETES Self Directed Test (12 Hours) Name: Ward/Practice Area: Mailing Address: 2 Learning Outcomes All nurses, regardless of practice setting, are required to work collaboratively with the person

More information

Improving Glycemic Control in Non-Critical Care Units Kristen Kulasa, MD

Improving Glycemic Control in Non-Critical Care Units Kristen Kulasa, MD Improving Glycemic Control in Non-Critical Care Units Kristen Kulasa, MD Glycemic Control Bootcamp December 9, 2016 PRESENTER: So Dr. [INAUDIBLE] will go back out and come back in with her moves. We'll

More information

Great Lakes Partners for Patients: Hospital Improvement Innovation Network - Encyclopedia of Measures Frequently Asked Questions

Great Lakes Partners for Patients: Hospital Improvement Innovation Network - Encyclopedia of Measures Frequently Asked Questions Great Lakes Partners for Patients: Hospital Improvement Innovation Network - Encyclopedia of Measures Frequently Asked Questions Contents Great Lakes Partners for Patients: Hospital Improvement Innovation

More information

Stroke Hyperglycemia Insulin Network Effort (SHINE) Trial Treatment Protocols. Askiel Bruno, MD, MS Protocol PI

Stroke Hyperglycemia Insulin Network Effort (SHINE) Trial Treatment Protocols. Askiel Bruno, MD, MS Protocol PI Stroke Hyperglycemia Insulin Network Effort (SHINE) Trial Treatment Protocols Askiel Bruno, MD, MS Protocol PI SHINE Synopsis Acute ischemic stroke

More information

Implementing Glucose Control in 2009 and Beyond: Changes in Patterns and Perceptions

Implementing Glucose Control in 2009 and Beyond: Changes in Patterns and Perceptions Implementing Glucose Control in 2009 and Beyond: Changes in Patterns and Perceptions Charles C. Reed MSN, RN, CNRN Patient Care Coordinator Surgical Trauma ICU University Hospital San Antonio, Texas Relationships

More information

Welcome Everyone. Monitoring, Sick Days, Inpatient Management - Objectives. Mrs. Jones has new diabetes. She asks you: Page 1

Welcome Everyone. Monitoring, Sick Days, Inpatient Management - Objectives. Mrs. Jones has new diabetes. She asks you: Page 1 Welcome Everyone Sign-In Enjoy Breakfast Meet someone new Enter Raffle Pick a team name Please silence phones We start at 8:00am Monitoring, Sick Days, Inpatient Management - Objectives Objectives: Strategies

More information

The Diabetes Guidelines Trek: The Next Generation. Inpatient Diabetes Guidelines. Learning Objectives. Current Inpatient Guidelines

The Diabetes Guidelines Trek: The Next Generation. Inpatient Diabetes Guidelines. Learning Objectives. Current Inpatient Guidelines The Diabetes Guidelines Trek: The Next Generation J. Christopher Lynch, PharmD, BCACP Southern Illinois University Edwardsville School of Pharmacy Susan Cornell BS, PharmD, CDE, FAPhA, FAADE Midwestern

More information

Quality Improvement Impact Activity for Insulin Pen Safety. Kosair Children s Hospital Louisville, Kentucky

Quality Improvement Impact Activity for Insulin Pen Safety. Kosair Children s Hospital Louisville, Kentucky Quality Improvement Impact Activity for Insulin Pen Safety Kosair Children s Hospital Louisville, Kentucky Tristan Murray, Pharm.D., BCPS, Team Leader June 2015 Team Members Tristan Murray, Pharm.D., BCPS

More information

LOUISIANA MEDICAID PROGRAM ISSUED: 02/01/12 REPLACED: 02/01/94 CHAPTER 5: PROFESSIONAL SERVICES SECTION 5.1: COVERED SERVICES PAGE(S) 6

LOUISIANA MEDICAID PROGRAM ISSUED: 02/01/12 REPLACED: 02/01/94 CHAPTER 5: PROFESSIONAL SERVICES SECTION 5.1: COVERED SERVICES PAGE(S) 6 Diabetes Education Management Training Diabetes self management training (DSMT) is a collaborative process through which recipients with diabetes gain knowledge and skills needed to modify behavior and

More information

Objectives 2/13/2013. Figuring out the dose. Sub Optimal Glycemic Control: Moving to the Appropriate Treatment

Objectives 2/13/2013. Figuring out the dose. Sub Optimal Glycemic Control: Moving to the Appropriate Treatment Sub Optimal Glycemic Control: Moving to the Appropriate Treatment Judy Thomas, MSN, FNP-BC Holt and Walton, Rheumatology and Endocrinology Objectives Upon completion of this session you will be better

More information

A Call to Action: Addressing Diabetes Medication Safety

A Call to Action: Addressing Diabetes Medication Safety A Call to Action: Addressing Diabetes Medication Safety Evan M. Klass, M.D., F.A.C.P. Senior Associate Dean, Statewide Initiatives Reducing ED visits for insulin induced hypoglycemia is a Healthy People

More information

Glucose Management in the ICU: The Role of the Pharmacist

Glucose Management in the ICU: The Role of the Pharmacist Objectives Glucose Management in the ICU: The Role of the Pharmacist James Gilmore PharmD, BCPS Senior Pharmacist- Surgical Intensive Care Unit Brigham and Women s Hospital Boston, MA Evaluate primary

More information

Quality Improvement through HIT

Quality Improvement through HIT Quality Improvement through HIT What is quality in healthcare? Safe Effective Patientcentered Timely Efficient Equitable Overview Reinforce a vision for using HIT to improve quality Share our approach

More information

Report Reference Guide

Report Reference Guide Report Reference Guide How to use this guide Each type of CareLink report and its components are described in the following sections. Report data used to generate the sample reports was from sample patient

More information

Case Study. Patient Profile. Baseline Report - Daily Patterns. Insights

Case Study. Patient Profile. Baseline Report - Daily Patterns. Insights Case Study Patient Profile Sex/Age: Female, 48 years old Disease diagnosis: Type 2 for past 13 years, coronary artery disease for 3 years, complains of severe tiredness HbA1c: 9.0% Diabetes medication

More information

First-in-Class Treatment for Hyperinsulinemic Hypoglycemia. January 31, 2017

First-in-Class Treatment for Hyperinsulinemic Hypoglycemia. January 31, 2017 358 First-in-Class Treatment for Hyperinsulinemic Hypoglycemia January 31, 2017 Forward-Looking Statement Certain statements contained herein including, but not limited to, expected licensing transactions,

More information

1. Continuous Glucose Monitoring

1. Continuous Glucose Monitoring 1. Continuous Glucose Monitoring 1. Physiology of interstitial fluid glucose 2. Comparison of CGM and self-monitored blood glucose (SMBG) data 3. Insulin dosing indication in BGM vs. CGM & the FDA 4. Protection

More information

OneTouch Reveal web app Report Reference Guide

OneTouch Reveal web app Report Reference Guide OneTouch Reveal web app Report Reference Guide Your step-by-step guide to setting up and using the OneTouch Reveal web app OneTouch Verio meter OneTouch Verio Flex meter OneTouch Verio IQ meter OneTouch

More information

Getting Off the Merry-Go-Round Reducing Readmissions for Patients with Diabetes

Getting Off the Merry-Go-Round Reducing Readmissions for Patients with Diabetes Getting Off the Merry-Go-Round Reducing Readmissions for Patients with Diabetes Kristi Kulasa, MD Associate Clinical Professor of Medicine Director, Inpatient Glycemic Control University of California

More information

Inpatient Insulin: A Team Approach

Inpatient Insulin: A Team Approach Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/clinicians-roundtable/inpatient-insulin-a-team-approach/3763/

More information

It s Just a Waived Glucose, Isn t It?

It s Just a Waived Glucose, Isn t It? It s Just a Waived Glucose, Isn t It? What Is the Next Step? Becky Damiani, MT (ASCP), Senior Inspection Specialist Laboratory Accreditation Program Objectives Understand the CLIA requirements surrounding

More information